Tagged with access,

Global A new book by two pharma industry experts offers the first truly global perspective on the complexities of market access.   Even the most innovative drug is useless if patients cannot afford or access it. As pharmaceutical innovation advances, market access strategies – determining who gets a drug, at what…

APAC Dengue fever is highly endemic in almost every country in Southeast Asia, meaning that Takeda – having launched its dengue vaccine in 2023 – stands to have a massive impact on health in the region. In conversation, Takeda’s Area Head for India and Southeast Asia Dion Warren outlines how Takeda’s…

Saudi Arabia Lyes Salah, General Manager of Amgen Saudi Arabia, delves into the company’s commitment to supporting Saudi Vision 2030 through innovation, strategic partnerships, and talent development. By advancing healthcare accessibility, fostering diversity, and driving digital transformation, Amgen plays a pivotal role in the Kingdom’s healthcare transformation.   Success is not an…

Saudi Arabia AstraZeneca has made remarkable progress over the past three years in Saudi Arabia, gaining significant leadership in therapeutic areas like oncology and respiratory care, and expansion into rare diseases. Sameh ElFangary, Country President of AstraZeneca GCC & Pakistan shares insights into the company’s strategy and strong alignment with Saudi Arabia’s…

Puerto Rico Juan Ignacio Diddi, GM of BMS Puerto Rico & Caribbean, has over 20 years of experience in the pharmaceutical industry, having held various roles across Latin America before taking on the role leading BMS Puerto Rico and the Caribbean in 2022. He focuses on ensuring early access to therapies, fostering…

Switzerland Industry stakeholders are raising the alarm about access to innovative medicines in Switzerland. Do delays in market access compared to other countries in Europe not only threaten the health of patients in Switzerland, but the country’s status as a global biopharmaceutical R&D hub?   Major Challenges As outlined elsewhere in…

China Jens Ewert, Life Science and Health Care Industry Leader at Deloitte China, provides an in-depth analysis of the development of China’s healthcare landscape over the previous past four years. Ewert highlights key trends such as the growing role of local biopharma players, the impact of value-based pricing, and the changing…

China Deng Haoqing, President and General Manager of Chiesi China, explores the company’s strategic growth in one of the world’s most dynamic healthcare markets. Deng discusses the alignment of Chiesi’s “AIR, CARE, and RARE” focus with China’s evolving healthcare priorities, highlighting efforts to bring innovation through local and global collaborations, including…

UAE Sanofi’s Preeti Futnani explores the rapid healthcare transformation underway in the UAE and Saudi Arabia, where governments are increasingly prioritising innovation and how Sanofi is leveraging its strong relationships and pipeline of breakthrough medications to align with regional goals. She touches on how Sanofi GCC is integrating digital tools to…

UAE Baptiste de Clarens lays out how Sanofi is leveraging its innovative vaccine pipeline, including high-dose flu vaccines and RSV monoclonal antibodies, to drive growth in the GCC region. Despite challenges like vaccine scepticism in adult immunisation, the company is focused on strengthening vaccination infrastructure and public health awareness. de Clarens…

Switzerland Jörg Storre, General Manager of CSL Vifor Pharma Switzerland, explores the company’s historical legacy and current focus on innovative iron therapies and nephrology. Storre highlights some of his strategic priorities, including improving patient care and access, fostering talent development, and maintaining supply security within a competitive landscape.    When employees…

Switzerland Anne Mette Wiis Vogelsang, CVP & General Manager of Novo Nordisk Switzerland, discusses Switzerland’s progressive healthcare landscape while addressing key issues like diabetes care, obesity, and systemic healthcare challenges. Vogelsang also calls for increased prioritization of a holistic approach to health, highlighting the importance of primary and secondary prevention, early…